Dividend logo

When investors think of biotech stocks, the word “lottery” comes to mind. And for the most part, they are right. The vast bulk of the sector made up of smaller, early-stage drug developers with only one, or maybe two, new therapies in development. These firms live or die by how one drug performs. Fail the first round of a clinical trial and the stock is done for. Make it past the FDA’s watch and the stock soars.

A “lottery ticket” is certainly an accurate comparison when it comes to investing in biotech.

To read the Full Story, Go Premium or Log In

Popular Articles

Premium Dividend%20aristocrat%20with%2050%20%20years%20of%20dividend%20increases%20reaffirms%20its%20position%20on%20best%20dividend%20stocks%20list
News

Dividend Aristocrat With 50+ Years of Dividend Increases Reaffirms its Position on Best Dividend Stocks List

If there has been one dominating headline over the last few quarters, it has to be the U.S./China...

News

Lowe's Companies, Caterpillar and PNC Financial Increase Dividend

Each week, stocks, funds and REITs announce upcoming dividend payouts. Track how your portfolio’s...

Practice Management

3 Must-Read Pieces for Practice Management: July 15 Edition

Every month, we bring you a curated list of must-read articles geared towards helping you grow...